Archean Chemical Industries quarterly results

·ChemicalsChart ›
Q2 FY27 · Jul–Sep 2026
₹ croreQ2 FY27Q2 FY26Change
Revenue297233+27.5%
EBITDA70.262.6+12.1%
EBITDA margin23.6%26.9%−3.2 pts
Profit before tax45.739.9+14.6%
Net profit31.329.0+7.9%
EPS₹2.60₹2.36+10.2%

Every quarter

₹ crore except per share
Tap a line for its trendQ2 FY27Sep 2026Q1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025Q3 FY25Dec 2024Q2 FY25Sep 2024Q1 FY25Jun 2024Q4 FY24Mar 2024Q3 FY24Dec 2023Earlier quartersAlpha Plus
297327301255233292346242240213284413
Earlier quartersEvery year the company has filed comes with Alpha Plus.
4.35.65.47.06.48.27.88.910.99.712.09.2
302333306262240301353251251222296422
Expenses
44.138.525.515.412.734.122.911.714.813.612.29.9
0.00.00.00.00.016.50.00.00.00.00.00.0
−21.6−7.913.7−16.4−12.5−24.8−10.5−27.5−1.1−31.7−20.137.0
19.419.321.317.316.918.719.613.912.814.714.718.2
4.95.510.44.45.55.40.32.93.21.71.71.9
23.923.222.823.623.622.921.120.119.518.617.717.7
185210197184154170225164139145190202
256289290228200243279185188162216287
70.267.343.754.462.678.188.379.974.771.287.1145
46.344.120.930.839.055.267.259.855.352.669.5128
Profit
45.744.215.933.339.958.074.765.763.060.679.7135
0.00.00.00.00.00.00.00.0−40.20.00.00.0
45.744.215.933.339.958.074.765.722.860.679.7135
14.417.111.712.110.919.325.019.16.315.020.832.1
−0.0−3.2−8.1−2.8−0.0−1.5−4.0−1.10.70.71.41.5
14.413.93.69.310.917.920.917.97.015.722.133.6
31.330.412.224.029.040.153.747.815.744.857.6102
31.330.412.224.029.040.153.747.815.744.857.6102
−0.0−0.1−0.0−0.1−0.10.0−0.10.0−0.10.0−0.10.0
31.330.312.223.928.940.253.747.815.644.957.5102
32.130.7—23.629.140.253.548.015.844.957.6102
−0.7−0.3—0.4−0.1−0.00.2−0.1−0.0−0.0−0.00.0
Per share
₹2.60₹2.48₹1.13₹1.92₹2.36₹3.25₹4.33₹3.89₹1.28₹3.64₹4.65₹8.24
₹2.60₹2.48₹1.12₹1.92₹2.36₹3.25₹4.32₹3.88₹1.27₹3.63₹4.64₹8.23
Other comprehensive income — detail
−0.0−0.1−0.0−0.1−0.10.0−0.1—————
−0.0−0.1−0.0−0.2−0.10.0−0.10.0−0.20.0−0.10.0
−0.0−0.0−0.0−0.0−0.00.0−0.0—————
———————0.0−0.00.0−0.00.0
32.030.6—23.529.040.253.548.015.644.957.5102
−0.7−0.3—0.4−0.1−0.00.2−0.1−0.0−0.0−0.00.0
Per share — as-filed variants
₹2.60₹2.48₹1.13₹1.92₹2.36₹3.25₹4.33₹3.89₹1.28₹3.64₹4.65₹8.24
₹2.60₹2.48₹1.12₹1.92₹2.36₹3.25₹4.32₹3.88₹1.27₹3.63₹4.64₹8.23
Derived — gross profit (revenue − materials − purchases − Δ inventories)
275297262255233267333258227231292366
92.4%90.6%86.9%100.4%99.9%91.2%96.4%106.5%94.3%108.5%102.8%88.6%
Adjusted (ex-exceptional items) — derived
45.744.215.933.339.958.074.765.763.060.679.7135
0.00.00.00.00.00.00.00.0−40.20.00.00.0
31.330.412.224.029.040.153.747.843.544.857.6102
₹2.60₹2.48₹1.13₹1.92₹2.36₹3.25₹4.33₹3.89₹3.54₹3.64₹4.65₹8.24
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACI₹454.40

Archean Chemical Industries Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersNEOGENAETHERALKYLAMINEBALAMINESTECILCHEMELLENGHCLGNFCMcap ₹5,610 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Revenue from Operations412.6283.9212.7240.5242.3345.6292.4233.2254.6300.9327.2297.4
Other Income9.212.09.710.98.97.88.26.47.05.45.64.3
Total Income421.9295.9222.4251.4251.1353.4300.6239.6261.5306.3332.8301.6
Expenses
+ Cost of Materials Consumed9.912.213.614.811.722.934.112.715.425.538.544.1
+ Purchases of Stock-in-Trade0.00.00.00.00.00.016.50.00.00.00.00.0
+ Changes in Inventories37.0-20.1-31.7-1.1-27.5-10.5-24.8-12.5-16.413.7-7.9-21.6
+ Employee Benefit Expense18.214.714.712.813.919.618.716.917.321.319.319.4
+ Finance Costs1.91.71.73.22.90.35.45.54.410.45.54.9
+ Depreciation & Amortisation17.717.718.619.520.121.122.923.623.622.823.223.9
+ Other Expenses202.0190.0144.8139.2164.2225.3169.7153.6183.8196.7210.0185.2
Total Expenses286.7216.1161.8188.4185.4278.7242.6199.7228.2290.5288.6255.9
EBITDA145.487.171.274.779.988.378.162.654.443.767.370.2
EBIT127.869.552.655.359.867.255.239.030.820.944.146.3
Profit
PBT before Exceptional Items135.179.760.663.065.774.758.039.933.315.944.245.7
+ Exceptional Items0.00.00.0-40.20.00.00.00.00.00.00.00.0
Pretax Income135.179.760.622.865.774.758.039.933.315.944.245.7
+ Current Tax32.120.815.06.319.125.019.310.912.111.717.114.4
+ Deferred Tax1.51.40.70.7-1.1-4.0-1.5-0.0-2.8-8.1-3.2-0.0
Tax Expense33.622.115.77.017.920.917.910.99.33.613.914.4
Net Income101.557.644.815.747.853.740.129.024.012.230.431.3
+ Net Income — Continuing Ops101.557.644.815.747.853.740.129.024.012.230.431.3
+ Other Comprehensive Income0.0-0.10.0-0.10.0-0.10.0-0.1-0.1-0.0-0.1-0.0
Total Comprehensive Income101.557.544.915.647.853.740.228.923.912.230.331.3
Net Income to Common101.557.644.915.848.053.540.229.123.6—30.732.1
Minority Interest0.0-0.0-0.0-0.0-0.10.2-0.0-0.10.4—-0.3-0.7
Per Share
Basic EPS8.244.653.641.283.894.333.252.361.921.132.482.60
Diluted EPS8.234.643.631.273.884.323.252.361.921.122.482.60
Other Comprehensive Income — detail
+ Other Comprehensive Income—————-0.10.0-0.1-0.1-0.0-0.1-0.0
+ Items NOT to be Reclassified to P&L0.0-0.10.0-0.20.0-0.10.0-0.1-0.2-0.0-0.1-0.0
+ Tax on Items NOT to be Reclassified—————-0.00.0-0.0-0.0-0.0-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag0.0-0.00.0-0.00.0———————
Comprehensive Income — Owners of Parent101.557.544.915.648.053.540.229.023.5—30.632.0
Comprehensive Income — Non-controlling Interests0.0-0.0-0.0-0.0-0.10.2-0.0-0.10.4—-0.3-0.7
Per Share — as-filed variants
Basic EPS — Continuing Operations8.244.653.641.283.894.333.252.361.921.132.482.60
Diluted EPS — Continuing Operations8.234.643.631.273.884.323.252.361.921.122.482.60
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit365.7291.8230.7226.8258.1333.2266.6233.1255.5261.7296.6274.8
Gross Margin %88.62102.79108.4894.31106.5296.4391.1899.94100.3786.9590.6592.43
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)135.179.760.663.065.774.758.039.933.315.944.245.7
− Exceptional Items (reconciliation)0.00.00.0-40.20.00.00.00.00.00.00.00.0
Net Income Adj (tax-effected)101.557.644.843.547.853.740.129.024.012.230.431.3
EPS Adj8.244.653.643.543.894.333.252.361.921.132.482.60
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital24.724.724.724.724.724.724.724.724.724.724.724.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Archean Chemical Industries Q2 FY27 results (July–September 2026)

Filed with NSE on Thursday, 29 October 2026 at 6:30 pm IST

Archean Chemical Industries (NSE: ACI) reported its Q2 FY27 results (July–September 2026) on Thursday, 29 October 2026 at 6:30 pm IST. Consolidated net profit attributable to shareholders was ₹32.1 crore, up 10.2% from ₹29.1 crore in Q2 FY26 and up 4.5% from ₹30.7 crore in Q1 FY27. Revenue from operations was ₹297 crore, up 27.5% year on year and down 9.1% from the previous quarter.

Q3 FY27 results due by
14 February 2027

Q2 FY27 at a glance · consolidated

Net profit (shareholders')
₹32.1 Cr+10.2% vs Q2 FY26+4.5% vs Q1 FY27Total incl. minority interest ₹31.3 Cr
Revenue from operations
₹297 Cr+27.5% vs Q2 FY26−9.1% vs Q1 FY27
Operating margin (EBIT)
15.6%−1.2 pts vs Q2 FY26+2.1 pts vs Q1 FY27EBIT ₹46.3 Cr
EBITDA
₹70.2 Cr+12.1% vs Q2 FY26+4.4% vs Q1 FY27margin 23.6%
Earnings per share (basic)
₹2.60+10.2% vs Q2 FY26+4.8% vs Q1 FY27
Net profit margin
10.8%−1.7 pts vs Q2 FY26+1.4 pts vs Q1 FY27

Questions

What was Archean Chemical Industries' net profit in Q2 FY27?

Consolidated net profit attributable to shareholders was ₹32.1 crore, up 10.2% from ₹29.1 crore in Q2 FY26 and up 4.5% from ₹30.7 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹31.3 crore.

How were Archean Chemical Industries' Q2 FY27 results?

Both grew from a year earlier: net profit was up 10.2% at ₹32.1 crore and revenue was up 27.5% at ₹297 crore. The operating margin was 15.6%, down 1.2 percentage points from 16.7% a year earlier. Against Q1 FY27, net profit was up 4.5% and revenue down 9.1%.

What was Archean Chemical Industries' operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹46.3 crore, a margin of 15.6%, against 13.5% in Q1 FY27 and 16.7% in Q2 FY26. EBITDA was ₹70.2 crore, 23.6% of revenue.

What was Archean Chemical Industries' revenue in Q2 FY27?

Revenue from operations was ₹297 crore, up 27.5% year on year and down 9.1% from the previous quarter.

What was Archean Chemical Industries' EPS in Q2 FY27?

Basic earnings per share were ₹2.60, against ₹2.36 in Q2 FY26.

When did Archean Chemical Industries announce its Q2 FY27 results?

On Thursday, 29 October 2026 at 6:30 pm IST, in its results filing to the stock exchanges.

What was Archean Chemical Industries' net profit in the first half of FY27?

Consolidated net profit attributable to shareholders for the first half of FY27 (April–September 2026) was ₹62.7 crore, down 9.4% from ₹69.3 crore in the same months a year earlier. Revenue from operations was ₹625 crore, up 18.8%.

What is Archean Chemical Industries' net profit margin?

Archean Chemical Industries' net profit margin was 10.8% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations), against 12.5% in Q2 FY26 (down 1.7 percentage points). For FY26 as a whole it was 9.8%.

What was Archean Chemical Industries' net profit in FY26?

Consolidated net profit attributable to shareholders was ₹105 crore in FY26 (April 2025–March 2026), down 35.0% from ₹162 crore in FY25. It was ₹319 crore in FY24 and ₹383 crore in FY23: down 72.4% over three years, an average fall of 34.9% a year.

How has Archean Chemical Industries' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹23.6 crore in Q3 FY26, ₹12.2 crore in Q4 FY26, ₹30.7 crore in Q1 FY27 and ₹32.1 crore in Q2 FY27. That is ₹98.6 crore over the four quarters, down 42.3% from ₹171 crore in the four quarters before. Revenue from operations: ₹255 crore, ₹301 crore, ₹327 crore and ₹297 crore.

What was Archean Chemical Industries' revenue in FY26?

Revenue from operations was ₹1,081 crore in FY26 (April 2025–March 2026), up 3.8% from ₹1,041 crore in FY25. It was ₹1,330 crore in FY24 and ₹1,441 crore in FY23: down 25.0% over three years, an average fall of 9.1% a year.

When will Archean Chemical Industries announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Archean Chemical Industries figures come from?

From Archean Chemical Industries' own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 29 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.